Research Paper Impact of combining vitamin C with radiation therapy in human breast cancer : Does it matter?
(2022) In Oncotarget 13(1). p.439-453- Abstract
 Vitamin C may impact the efficiency of radiation therapy (RT) in breast cancer. The effects of RT alone or in combination with vitamin C in SKBR3, MDA-MB-231, and MCF7 cells were compared using clonogenic assay, proliferation assay (MTT), cell cycle analysis, and Western blot. Vitamin C use was assessed in 1803 breast cancer patients 2002–2017 in relation to clinicopathological features and recurrences after RT. Vitamin C combined with RT resulted in non-significant increases in colony formation and minor differences in cell cycle arrest and expression of studied proteins, compared to RT alone. Lower vitamin C doses alone or in combination with RT, resulted in higher proliferation with MTT than higher vitamin C doses in a cell... (More)
Vitamin C may impact the efficiency of radiation therapy (RT) in breast cancer. The effects of RT alone or in combination with vitamin C in SKBR3, MDA-MB-231, and MCF7 cells were compared using clonogenic assay, proliferation assay (MTT), cell cycle analysis, and Western blot. Vitamin C use was assessed in 1803 breast cancer patients 2002–2017 in relation to clinicopathological features and recurrences after RT. Vitamin C combined with RT resulted in non-significant increases in colony formation and minor differences in cell cycle arrest and expression of studied proteins, compared to RT alone. Lower vitamin C doses alone or in combination with RT, resulted in higher proliferation with MTT than higher vitamin C doses in a cell line-dependent manner. Vitamin C use was associated with lower histological grade and BMI but not recurrence risk in RT-treated patients (LogRank P = 0.54). Vitamin C impacted RT efficiency differently depending on breast cancer subtype and vitamin C concentration. Lower doses of vitamin C, achievable with oral administration, might increase breast cancer cell proliferation and decrease radiosensitivity. Despite vitamin C users having less aggressive tumors than non-users, the recurrence risk in RT-treated patients was similar in vitamin C users and non-users.
(Less)
- author
 - 						Khazaei, Somayeh
				LU
	; 						Nilsson, Linn
				LU
	; 						Adrian, Gabriel
				LU
				
	; 						Tryggvadottir, Helga
				LU
	; 						Konradsson, Elise
				LU
	; 						Borgquist, Signe
				LU
	; 						Isaksson, Karolin
				LU
	; 						Ceberg, Crister
				LU
				
	 and 						Jernström, Helena
				LU
	 - organization
 - 
                
- Division of Hematology and Clinical Immunology
 - LUCC: Lund University Cancer Centre
 - Cancerepidemiology and radiation
 - Radiation therapy
 - Epidemiology and pharmacogenetics (research group)
 - Medical Radiation Physics, Lund
 - Radiotherapy Physics (research group)
 - Breast cancer prevention & intervention (research group)
 - Breastcancer
 - Surgery (Lund)
 - EpiHealth: Epidemiology for Health
 
 - publishing date
 - 2022
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - keywords
 - clinical outcome, human breast cancer, in vitro, radiation therapy, vitamin C
 - in
 - Oncotarget
 - volume
 - 13
 - issue
 - 1
 - pages
 - 15 pages
 - publisher
 - Impact Journals
 - external identifiers
 - 
                
- scopus:85127062809
 
 - ISSN
 - 1949-2553
 - DOI
 - 10.18632/ONCOTARGET.28204
 - language
 - English
 - LU publication?
 - yes
 - id
 - 270d579f-356b-4fe6-98a4-0a44478a7de7
 - date added to LUP
 - 2022-06-03 13:39:21
 - date last changed
 - 2025-10-14 11:01:11
 
@article{270d579f-356b-4fe6-98a4-0a44478a7de7,
  abstract     = {{<p>Vitamin C may impact the efficiency of radiation therapy (RT) in breast cancer. The effects of RT alone or in combination with vitamin C in SKBR3, MDA-MB-231, and MCF7 cells were compared using clonogenic assay, proliferation assay (MTT), cell cycle analysis, and Western blot. Vitamin C use was assessed in 1803 breast cancer patients 2002–2017 in relation to clinicopathological features and recurrences after RT. Vitamin C combined with RT resulted in non-significant increases in colony formation and minor differences in cell cycle arrest and expression of studied proteins, compared to RT alone. Lower vitamin C doses alone or in combination with RT, resulted in higher proliferation with MTT than higher vitamin C doses in a cell line-dependent manner. Vitamin C use was associated with lower histological grade and BMI but not recurrence risk in RT-treated patients (LogRank P = 0.54). Vitamin C impacted RT efficiency differently depending on breast cancer subtype and vitamin C concentration. Lower doses of vitamin C, achievable with oral administration, might increase breast cancer cell proliferation and decrease radiosensitivity. Despite vitamin C users having less aggressive tumors than non-users, the recurrence risk in RT-treated patients was similar in vitamin C users and non-users.</p>}},
  author       = {{Khazaei, Somayeh and Nilsson, Linn and Adrian, Gabriel and Tryggvadottir, Helga and Konradsson, Elise and Borgquist, Signe and Isaksson, Karolin and Ceberg, Crister and Jernström, Helena}},
  issn         = {{1949-2553}},
  keywords     = {{clinical outcome; human breast cancer; in vitro; radiation therapy; vitamin C}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{439--453}},
  publisher    = {{Impact Journals}},
  series       = {{Oncotarget}},
  title        = {{Research Paper Impact of combining vitamin C with radiation therapy in human breast cancer : Does it matter?}},
  url          = {{http://dx.doi.org/10.18632/ONCOTARGET.28204}},
  doi          = {{10.18632/ONCOTARGET.28204}},
  volume       = {{13}},
  year         = {{2022}},
}